2nd Quarter - Report

EMD SERONO, INC. for EMD SERONO INC

Firm
Client
Income
—
Expenses
$570,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

HR3221: FORECLOSURE PREVENTION ACT OF 2008; ACCELERATION OF R&D/AMT CREDITS (AS AMENDED BY SENATE) S3125: ENERGY INDEPENDENCE AND TAX RELIEF ACT OF 2008; SECTION 221-EXTENSION AND MODIFICATION RESEARCH CREDIT HR6049: RENEWABLE ENERGY AND JOB CREATION ACT OF 2008, R&D TAX CREDIT

LobbyistCovered position, as disclosed
DAVID NICHOLS N/A
LYNN TAYLOR N/A

Contacted: Patent & Trademark Office (PTO); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6049 (110th), H.R. 3221 (110th)

Copyright/Patent/Trademark CPT

HR 1908/S1145: PATENT REFORM ACT OF 2007; ALL PROVISIONS OF THE BILL

LobbyistCovered position, as disclosed
DAVID NICHOLS N/A
LYNN TAYLOR N/A

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1908 (110th)

Medicare/Medicaid MMM

HR2606/S1376: 340B PROGRAM IMPROVEMENT AND INTEGRITY ACT OF 2007; 340B DRUG PRICE EXPANSION HR3162: CHILDREN'S HEALTH AND MEDICARE PROTECTION ACT OF 2007; ALL PROVISIONS OF THE BILL HR4/S3: MEDICARE PRESCRIPTION DRUG PRICE NEGOTIATION ACT OF 2007; MEDICARE "NON-INTERFERENCE" PROVISIONS HR5480: MEDICARE FUNDING WARNING RESPONSE ACT OF 2008; ALL PROVISIONS OF THE BILL S2029: PHYSICIAN PAYMENT SUNSHINE ACT OF 2007; ALL PROVISIONS OF THE BILL S2662: MEDICARE FUNDING WARNING RESPONSE ACT OF 2008; ALL PROVISIONS OF THE BILL HR6331/S3101: MEDICARE IMPROVEMENTS FOR PATIENTS AND PROVIDERS ACT OF 2008; COMPARATIVE EFFECTIVENESS PROVISION COMPARATIVE EFFECTIVENESS ISSUES

LobbyistCovered position, as disclosed
DAVID NICHOLS N/A
LYNN TAYLOR N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2606 (110th), H.R. 4 (110th), H.R. 3162 (110th), H.R. 5480 (110th), H.R. 6331 (110th)

Budget/Appropriations BUD

S3230: LABOR, HEALTH AND HUMAN SERVICES APPROPRIATIONS; DRUG IMPORTATION ISSUES DRUG IMPORTATION ISSUES HOUSE CONCURRENT RESOLUTION 312: HOUSE BUDGET RESOLUTION; TITLES II, III, VI SENATE CONCURRENT RESOLUTION 70: SENATE BUDGET RESOLUTION; TITLE III, SECTIONS 306, 307, 326, 331, 333 HR 2642: 2008 SUPPLEMENTAL APPROPRIATIONS ACT; CHAPTER 4 - PROVISIONS TO INCREASE NATIONAL INSTITUTES OF HEALTH FUNDING FOR CANCER RESEARCH COMPARATIVE EFFECTIVENESS ISSUES

LobbyistCovered position, as disclosed
DAVID NICHOLS N/A
LYNN TAYLOR N/A

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Patent & Trademark Office (PTO); Executive Office of the President (EOP)

Bills named: H.R. 2642 (110th)

Pharmacy PHA

S877: CONTROLLING THE ABUSE OF PRESCRIPTIONS ACT OF 2007; ALL PROVISIONS OF THE BILL HR4911: HUMAN GROWTH HORMONE RETRICTION ACT OF 2007; ALL PROVISIONS OF THE BILL DRUG IMPORTATION ISSUES HR1038/S623: ACCESS TO LIFE-SAVING MEDICINE ACT, FOLLOW-ON BIOLOGICS HR1956: PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINES ACT OF 2007; FOLLOW-ON BIOLOGICS PROVISIONS OF THE BILL HR5629: PATHWAY FOR BIOSIMILARS ACT; ALL PROVISIONS OF THE BILL S1505: AFFORDABLE BIOLOGICS FOR CONSUMERS ACT; FOLLOW-ON BIOLOGICS PROVISION OF THE BILL S1695: BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; FOLLOW-ON BIOLOGICS PROVISION OF THE BILL S2029: PHYSICIAN PAYMENTS SUNSHINE ACT OF 2007; ALL PROVISIONS OF THE BILL HR5839: THE SAFEGUARDING AMERICA'S PHARMACEUTICALS ACT OF 2008; ALL PROVISIONS OF THE BILL DRUG IMPORT SAFETY DRAFT

LobbyistCovered position, as disclosed
DAVID NICHOLS N/A
LYNN TAYLOR N/A

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4911 (110th), H.R. 1038 (110th), H.R. 1956 (110th), H.R. 5839 (110th), H.R. 5629 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.